SNPS can compound through resilient EDA demand, AI-driven tool consumption, and expanding custom-IP economics; the selloff and valuation gap improve entry.
The bullish growth case depends on monetization and customer budgets holding up; Intel exposure, constrained IP demand, and valuation sensitivity leave downside risk.
Mizuho views SNPS as a best opportunity after a recent selloff, following strong EDA demand and agentic AI updates.
Software: Mizuho sees ORCL/CDNS/SNPS/TWLO as best opportunities after selloff; positive on SHOP/FIVN into prints
Mizuho views last week’s ~5.6% IGV pullback as selective buying opportunity, favoring ORCL after Investor Day clarified AI-infra funding/FCF, CDNS/SNPS after strong EDA demand + agentic AI updates, and TWLO on improving fundamentals. Into earnings, it expec...
Upside was upfront-led (record hardware, IP +24%) while recurring grew 18%, and mgmt acknowledged customers aren’t yet paying meaningfully for agents; AI is monetizing indirectly through heavier base-tool usage. Investor focus on Maestro, a family of CDNS-p...
CDNS still discloses no agent revenue, and mgmt concedes customers are not yet paying significantly for agents, so the AI upside remains a promise. Customers are already scrutinizing token budgets, and startups are going after the agent layer too (NVDA also...
Wolfe reports that FY27 guidance was built with unusually high management visibility and does not imply a growth relapse in 2028.
GPT-Synopsys adds a new monetization layer through training-tool payments from OpenAI, customer subscriptions, and outcome-based fees, while the company retains customer relationships.
The company is still at a significant discount to CDNS, and tighter renewal discounting supports margins, leading Wolfe to reiterate an Outperform rating.
GPT-Synopsys adds a new monetization layer via training-tool payments from OpenAI, customer subscriptions and outcome-based fees tied to PPA improvements, while SNPS retains the customer relationship/GTM. With SNPS still at a >30% discount to CDNS and tight...
The company is exploring partnerships with Chinese AI labs to help local customers design chips faster using AI-powered tools, extending its AI design strategy into China.
The company surprised with strong FY27 revenue guidance, significantly above prior Street expectations, and lifted its long-term growth framework.
FY27/FY28 revenue/EPS estimates were raised due to stronger growth outlook, supported by ANSS synergies, AI-agent monetization, and a large AWS IP license deal.
AI is seen as a net tailwind for the company, contributing to its strong growth outlook.
Management targets mid-teens FY26–30 revenue CAGR, strong operating margin, and significant EPS by FY30, with AI agents expected to drive tool calls rather than cannibalize EDA.
Custom IP is stepping up, including a large multi-year AWS agreement and a strong IP growth target.
ANSS cost synergies are running a year ahead, and revenue synergies are ramping sooner, contributing to improved financial performance.
SNPS: JPM says Investor Day lays out path to ~$35 FY30 EPS, with AI + custom IP driving upside
JPM says after SNPS Investor Day, management now targets mid-teens FY26–30 revenue CAGR, ~50% OPM and ~$35 EPS by FY30, with AI agents expected to drive
The company's analyst day notes indicated a path to significantly higher FY30 EPS, with AI agents expected to drive increased tool usage rather than cannibalization.
The FY27 guidance for revenue and EPS is well above prior estimates, suggesting stronger-than-expected future performance.
The analyst day successfully addressed bear concerns regarding the EDA sector.
SNPS +12.8%; CDNS +6.2% as the analyst-day notes rolled in, with SNPS adding to yesterday’s +4.8%.
In Tech, we get SNPS analyst day, HPE Networking event (stock +4% after raising FY27 networking growth to highs teens/low 20s and increasing synergies target to $800M vs. $600M), and MU earnings (bogeys below).
The company secured a significant AWS license deal exceeding $1 billion, spanning multiple generations of AWS technologies.
The company provided early FY27 guidance with revenue growth of 15% and EPS growth of 27%, both exceeding consensus expectations.
The long-term revenue CAGR was raised to mid-teens through 2030 from double digits, indicating improved growth prospects.
The company announced "GPT-Synopsys" with OpenAI, an AI model for chip design structured to avoid cannibalizing existing business, with OpenAI paying a training subscription and revenue share.
The new custom-silicon IP business is projected to reach approximately $1 billion in revenue by FY30.
SNPS +4.8% had a busy day: a $1B+ AWS license deal spanning Graviton, Trainium and Nitro generations pre-market, then an analyst day with FY27 guidance two months early (revenue +15% to $11.15B vs. ~11% consensus; EPS +27% to $19.08; a $1B buyback) and the...
One analyst countered that the projected IP growth was already in line with high-teens expectations, suggesting less upside than perceived.
HSBC upgraded Synopsys to Buy and raised its price target to $700 from $490, citing a business model shift towards a licensing-plus-royalty model in Design IP and the potential for agentic AI to drive higher-value usage/consumption in EDA.
HSBC anticipates that these changes will drive revenue growth to approximately 15% in FY27, exceeding the consensus of 11%, and elevate the earnings CAGR from about 7% in FY24–26 to approximately 28% in FY26–28.
SNPS +3% on an HSBC upgrade while TWLO -4% on an HSBC downgrade.
The upcoming Investor Day could reset the AI-disruption narrative by demonstrating that frontier LLMs still require the company's EDA tools for simulation, verification, and synthesis, potentially turning AI into a consumption tailwind.
The analyst seeks proof that Factory 2 can restore Design IP growth as hyperscaler/custom-silicon demand scales, and that Ansys revenue synergies will begin contributing in FY27.
SNPS: MS says Investor Day could reset the AI-disruption narrative, with EDA + Factory 2 + Ansys synergies supporting upside
The company received an upgrade to Neutral from Underperform with a price target of $420, and its upcoming investor day is seen as a re-rating catalyst.
MS says Sept. 30 Investor Day could rebuild confidence by showing that frontier LLMs still need SNPS/CDNS EDA tools for simulation, verification and synthesis, turning AI from a disruption risk into a potential consumption tailwind.
In Tech, a lot of red with Semis/Software both down 2% and Internet -1%. Broad low liquidity de-grossing day: everything red except Telecom (+0.3%), with the damage concentrated in the high multiple growth: Security SW -5.3% (CRWD/S/NET/ZS/FTNT all -5% to -...
CDNS stands out more positively, with both accelerating hiring and relatively strong quota attainment, while falling headcount at SNPS, ADSK and PTC could support margins.
The setup for the IP business has materially improved as Intel's 18A and 14A nodes gain credibility.
Intel's emergence as a viable alternative to constrained TSMC capacity could drive a meaningful rebound in design activity at the company's largest IP customer, with potential upside from Google's TPU production plans and Apple's interest in Intel Foundry.
The market is underestimating the pace of an IP recovery, with renewed Intel foundry activity and future customer agreements creating a more favorable demand environment than investors expected.
The stock saw an increase, with some analysts suggesting that a competitor's commentary on internal EDA cuts could be positive for the company.
SNPS +1% as BNP was out calling out some of INTC’s LBT commentary as negative saying they imply potentially significant cuts to Intel’s EDA software licenses and engineering tool spend. Pushback I heard was that LBT talking about cutting INTC’s internal/cus...
Comments from Intel CEO Lip-Bu Tan imply potentially significant cuts to Intel’s EDA software licenses and engineering tool spend, which could become a negative read-through for Synopsys.
Intel has historically been one of Synopsys’s largest customers, and restructuring of Intel’s central engineering organization may lead to consolidation/reduction of overlapping EDA budgets.
The comments raise incremental risk ahead of SNPS earnings next week, despite unclear timing.
SNPS/CDNS/EDA: BNP Flags Potential Risk From Intel EDA License Cuts
Hyperscalers exploring Customer Owned Tooling (COT) for custom AI chips could drive a new wave of EDA spending, particularly on higher-priced back-end tools.
Job postings across major tech companies show growing demand for skills in Synopsys 3DIC Compiler, consistent with in-house chip design buildouts.
Activist Elliott built a multi-billion dollar stake, with Managing Partner Jesse Cohn stating that Synopsys is essential to the global chip industry and uniquely positioned to benefit from AI-driven chip complexity and capital investment.
Cohn said Elliott believes there is a “clear opportunity for Synopsys’ financial performance to more fully reflect the value it delivers.”
Cohn said the firm looks forward to engaging with the company, “to help align operational execution, profitability and monetization with its potential and importance to the semiconductor ecosystem.”
Piper Sandler downgraded the stock to Neutral from Overweight and lowered its price target to $520 from $602, citing expectations for prolonged growth headwinds as semiconductor engineering and fab capacity are increasingly reallocated toward AI and high-performance datacenter chips.
The analyst argues consumer-oriented designs are being "crowded out" as limited fabrication infrastructure is bid away by AI, creating risk to the company's approximately $1.75 billion IP business and setting up a more challenging 2026.
The stock's recent decline offers an attractive entry point as IP and China market trends begin to recover.
The integration of Ansys and workforce reductions are expected to support margins and revenue growth.
The stock has experienced a significant slide of approximately 30% since its Q3 print.
the new policy in FY26 guidance this week, while SNPS, CDNS, ORCL, and others with high R&D spend or capex intensity stand to benefit materially. Piper thinks these changes may accelerate near-term cash savings, sharpen strategic reinvestment priorities, an...
Research through 2026-11-02 · 2025-07-28 to 2026-11-02 · 17 source reports.
| Range | Prices through |
|---|---|
| 1W | |
| 1M | |
| 3M | |
| 6M | |
| 1Y | |
| 2Y | |
| 3Y |
Research through 2026-11-03. Artifact validity does not establish factual accuracy or research freshness.